Onconic Therapeutics Announces Extraordinary Shareholders Meeting

• Onconic Therapeutics will hold an extraordinary shareholders meeting on November 26, 2026, at Jeil Pharma Holdings Building in Seoul.
• Shareholders will consider raising the maximum board size to eight directors from seven.
• Proposals include appointing Park Young-jae and Lee Kyung-min as independent directors and audit committee members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconic Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016000459), on October 16, 2026, and is solely responsible for the information contained therein.